These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35361860)

  • 21. Functional Roles of Long Non-Coding RNAs (LncRNAs) in Glioma Stem Cells.
    Wang L; He Z
    Med Sci Monit; 2019 Oct; 25():7567-7573. PubMed ID: 31593561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.
    Wu J; Cai Y; Zhao G; Li M
    J Clin Lab Anal; 2021 Jun; 35(6):e23779. PubMed ID: 33934391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
    Li L; Xie R; Lu G
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal m6A modification in non-alcoholic fatty liver disease.
    Li Z; Qi J; Liu H; Tang Y; Liu J; Sun C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 46(8):785-792. PubMed ID: 34565720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Environmental exposures and RNA N6-Methyladenosine modified long Non-Coding RNAs.
    Cayir A
    Crit Rev Toxicol; 2020 Sep; 50(8):641-649. PubMed ID: 32924714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
    Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. METTL3-Mediated LncRNA
    Yang J; Yang Q; Huang X; Yan Z; Wang P; Gao X; Li J; Gun S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The functions of N6-methyladenosine modification in lncRNAs.
    He RZ; Jiang J; Luo DX
    Genes Dis; 2020 Dec; 7(4):598-605. PubMed ID: 33335959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma.
    Chen Y; Guo Y; Li S; Xu J; Wang X; Ning W; Ma L; Qu Y; Zhang M; Zhang H
    Front Oncol; 2022; 12():789283. PubMed ID: 35311131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N6-methyladenosine methylation mediates non-coding RNAs modification in microplastic-induced cardiac injury.
    Zhang M; Shi J; Zhou J; Song L; Ding J; Deng HP; Weng L; Zhu Y; Xu Z
    Ecotoxicol Environ Saf; 2023 Jun; 262():115174. PubMed ID: 37354568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analysis of the transcriptome-wide m6A methylome in colorectal cancer by MeRIP sequencing.
    Zhang Z; Wang Q; Zhang M; Zhang W; Zhao L; Yang C; Wang B; Jiang K; Ye Y; Shen Z; Wang S
    Epigenetics; 2021 Apr; 16(4):425-435. PubMed ID: 32749190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/β-catenin signaling.
    Yin J; Ding F; Cheng Z; Ge X; Li Y; Zeng A; Zhang J; Yan W; Shi Z; Qian X; You Y; Ding Z; Ji J; Wang X
    Cell Death Dis; 2023 Jul; 14(7):417. PubMed ID: 37438359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
    Yu ZL; Zhu ZM
    Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive Analysis of the Transcriptome-wide m6A Methylome in Lung Adenocarcinoma by MeRIP Sequencing.
    Mao W; Yu Q; Wang K; Ma Q; Zheng Y; Zhang G; Luo W; Wang N; Wang Y
    Front Oncol; 2022; 12():791332. PubMed ID: 35903698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exposure to bisphenol A affects transcriptome-wide N6-methyladenine methylation in ovarian granulosa cells.
    Zhang Y; Yan C; Xie Q; Wu B; Zhang Y
    Ecotoxicol Environ Saf; 2024 Mar; 272():116071. PubMed ID: 38354435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the Expressions and m6A Methylation Modification Patterns of mRNAs and lncRNAs in a Spinal Cord Injury Rat Model.
    Liu X; Li Z; Tong J; Wu F; Jin H; Liu K
    Mol Neurobiol; 2024 Jun; ():. PubMed ID: 38907070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptome-wide N6-methyladenosine modification profiling of mRNAs during infection of Newcastle disease virus in chicken macrophages.
    Li J; Ding J; Chen M; Chen K; Zou Y; Xu X; Zhang D; Yu X; Ding Z
    Virus Res; 2023 Jan; 323():198993. PubMed ID: 36326508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epitranscriptome of long noncoding RNAs in metabolic diseases.
    Yin L; Zhu X; Novák P; Zhou L; Gao L; Yang M; Zhao G; Yin K
    Clin Chim Acta; 2021 Apr; 515():80-89. PubMed ID: 33422492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma.
    Lin G; Wang H; Wu Y; Wang K; Li G
    Front Mol Biosci; 2021; 8():682471. PubMed ID: 34295922
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.